Angiogenic signaling pathways and anti-angiogenic therapy for cancer
ZL Liu, HH Chen, LL Zheng, LP Sun… - Signal transduction and …, 2023 - nature.com
Angiogenesis, the formation of new blood vessels, is a complex and dynamic process
regulated by various pro-and anti-angiogenic molecules, which plays a crucial role in tumor …
regulated by various pro-and anti-angiogenic molecules, which plays a crucial role in tumor …
Treatment options in recurrent ovarian cancer: latest evidence and clinical potential
D Luvero, A Milani… - Therapeutic advances in …, 2014 - journals.sagepub.com
Ovarian cancer (OC) is the fifth most common cause of cancer death in women. Although
significant progress has been made in the treatment of OC, the majority of patients …
significant progress has been made in the treatment of OC, the majority of patients …
Nanoceria: a rare-earth nanoparticle as a novel anti-angiogenic therapeutic agent in ovarian cancer
Ovarian cancer (OvCa) is the fifth most common cause of death from all cancers among
women in United Sates and the leading cause of death from gynecological malignancies …
women in United Sates and the leading cause of death from gynecological malignancies …
Targeted therapies for ovarian cancer
T Grunewald, JA Ledermann - Best practice & research Clinical obstetrics & …, 2017 - Elsevier
Epithelial ovarian cancer has the highest mortality rate of all gynaecological malignancies.
Most women present with advanced disease and develop a recurrence after radical surgery …
Most women present with advanced disease and develop a recurrence after radical surgery …
Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance
The molecular mechanism by which cancer-associated fibroblasts (CAFs) confer
chemoresistance in ovarian cancer is poorly understood. The purpose of the present study …
chemoresistance in ovarian cancer is poorly understood. The purpose of the present study …
Angiogenesis-related pathways in the pathogenesis of ovarian cancer
NG Gavalas, M Liontos, SP Trachana… - International journal of …, 2013 - mdpi.com
Ovarian Cancer represents the most fatal type of gynecological malignancies. A number of
processes are involved in the pathogenesis of ovarian cancer, especially within the tumor …
processes are involved in the pathogenesis of ovarian cancer, especially within the tumor …
Malignant ascites in ovarian cancer and the role of targeted therapeutics
E Smolle, V Taucher, J Haybaeck - Anticancer research, 2014 - ar.iiarjournals.org
Ovarian cancer (OC) is the eighth most lethal gynecological malignancy and the main cause
of gynecological cancer death in industrialized countries. Malignant ascites is often found in …
of gynecological cancer death in industrialized countries. Malignant ascites is often found in …
Neo-vascularization-based therapeutic perspectives in advanced ovarian cancer
The process of angiogenesis is well described for its potential role in the development of
normal ovaries, and physiological functions as well as in the initiation, progression, and …
normal ovaries, and physiological functions as well as in the initiation, progression, and …
Lymphatic vasculature in ovarian cancer
Ovarian cancer (OVCA) is the second most common gynecological cancer and one of the
leading causes of cancer related mortality among women. Recent studies suggest that …
leading causes of cancer related mortality among women. Recent studies suggest that …
Incorporation of anti-angiogenesis therapy in the management of advanced ovarian carcinoma—mechanistics, review of phase III randomized clinical trials, and …
RN Eskander, KS Tewari - Gynecologic oncology, 2014 - Elsevier
Despite survival gains achieved nearly two decades ago with combination platinum-and
taxane-based intravenous chemotherapy, overall survival curves have remained relatively …
taxane-based intravenous chemotherapy, overall survival curves have remained relatively …